Helper T cells, not killer T cells, might be responsible for clearing hepatitis A infection
Helper cells traditionally thought to only assist killer white blood cells may be the frontline warriors when battling hepatitis A infection. These are the findings from a Nationwide Children's Hospital study appearing in a recent issue of the Journal of Experimental Medicine.
Hepatitis A is a highly contagious liver infection caused by the hepatitis A virus. Despite the availability of an effective vaccine, the virus infects millions of people worldwide each year and remains a global public health problem, especially in underdeveloped countries.
Unlike the hepatitis C virus, the hepatitis A virus does not establish a persistent infection. Yet, up to 20 percent of patients can relapse several weeks after virus growth and after symptoms have disappeared.
"Mechanisms of immunity that protect against relapse, and why they occasionally fail, are unknown," said the study's lead author Christopher M. Walker, PhD, director of the Center for Vaccines and Immunity at The Research Institute at Nationwide Children's Hospital.
Research has shown that white blood cells known as CD8+ killer T cells play a critical role in controlling hepatitis C and hepatitis B virus infections. These T cells act by killing infected liver cells, a process that damages the liver, but is necessary to effectively shut off production of new viruses.
A study published more than 20 years ago suggested that killer T cells also control hepatitis A virus infection in humans. However, Dr. Walker observed a very different pattern of immunity while studying acute hepatitis A virus infection in animals.
He found that the infection was controlled well before an effective killer T cell response was generated. Hepatitis A virus growth was instead controlled by CD4+ T helper cells, a different type of white blood cell that normally assists in the activation killer T cells but, is not thought to directly engage virus-infected cells. In the two infected animals infected with the hepatitis A virus, helper T cells secreted factors that suppressed virus growth without causing serious liver damage or inflammation that is an undesirable byproduct of a killer T cell response.
Moreover, the helper T cells responded to resurgence in hepatitis A virus growth after initial control of the infection, and remained strong until the virus was finally eliminated from the liver several months later. These findings suggested that CD8+ T cells are not necessarily required to control hepatitis A virus infection. Instead, it appears that CD4+ T cells have a more direct role in stopping replication of the hepatitis A virus by mechanisms that do not involve severe damage to the liver.
"This is quite an unusual discovery," said Dr. Walker, also a faculty member at The Ohio State University College of Medicine. "These findings document a previously unappreciated role for CD4+ T cells in resolving acute hepatitis A, and perhaps in surveillance against a relapse in virus growth and liver disease that sometimes occurs in those with weak immune systems, particularly the very young and old."
If CD4+ T cells are found to play a similar role in humans, they could serve as a new target for preventing relapse of hepatitis A virus infection. An inefficient helper T cell response might explain why some patients relapse after clearing the infection.
"If CD4+ T cells have an immune surveillance function, as suggested by our findings, patients at greatest risk of relapsing liver disease may benefit from a vaccine that would boost helper T cell activity until the virus is finally cleared from the liver," said Dr. Walker.
Journal reference: Journal of Experimental Medicine
Provided by Nationwide Children's Hospital
- Hepatitis C virus blocks 'superinfection' Apr 05, 2007 | not rated yet | 0
- Hepatitis B virus triggers cell 'suicide' in patients with chronic infection Apr 08, 2008 | not rated yet | 0
- Hepatitis C kills more Americans than HIV: study Feb 23, 2012 | not rated yet | 0
- Possible hepatitis C vaccine Sep 05, 2007 | not rated yet | 0
- Protein found that slows hepatitis C growth in liver cells Apr 27, 2007 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011 I'd like to open a discussion thread for version 2 of the draft of my book ''Classical and Quantum Mechanics via Lie algebras'', available online at http://lanl.arxiv.org/abs/0810.1019 , and for the...
- More from Physics Forums - Independent Research
More news stories
(AP)—Government health officials are investigating several health problems reported with potentially contaminated medications made by a Tennessee specialty pharmacy.
Diseases, Conditions, Syndromes 19 hours ago | not rated yet | 0
(HealthDay)—Comorbid conditions often accompany alopecia areata, according to a study published online May 22 in JAMA Dermatology.
Diseases, Conditions, Syndromes 20 hours ago | not rated yet | 0
(HealthDay)—As a world-class golfer, Stacy Lewis' accomplishments are remarkable. But it was a physical challenge in her childhood that defined her ascent to the top of her sport.
Diseases, Conditions, Syndromes 21 hours ago | not rated yet | 0
Saudi Arabia said Friday it would send samples taken from animals possibly infected with a deadly SARS-like virus to the United States for testing in a bid to find the source of disease.
Diseases, Conditions, Syndromes May 24, 2013 | not rated yet | 0
The World Health Organization voiced deep concern Thursday over the SARS-like virus that has killed 22 people in less than a year, saying it might potentially spread more widely between humans.
Diseases, Conditions, Syndromes May 24, 2013 | 5 / 5 (1) | 0
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
3 hours ago | not rated yet | 4
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
22 hours ago | 3.7 / 5 (3) | 3 |
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
3 hours ago | not rated yet | 1
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
19 hours ago | 3 / 5 (2) | 0 |
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
22 hours ago | 5 / 5 (5) | 0 |
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
3 hours ago | not rated yet | 0